LOS ANGELES, Nov 7 (Reuters) - Early results from an ongoing study showed that people with newly diagnosed rheumatoid arthritis were more likely to reach clinical remission with Amgen Inc and Wyeth's ...

Amsterdam – Rheumatoid arthritis patients who are on standard methotrexate therapy may benefit from the addition of the biologic treatment, ENBREL* (etanercept), according to new data from a one-year, ...

THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) today announced new results from multiple studies of ENBREL, further expanding the ...

SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...

Troubled Amgen Inc.'s good news with Enbrel at the American College of Rheumatology (ACR) meeting came with another shoe dropping in the trouble over its anemia drugs - the labels of which are ...

Combining a new drug with the standard initial treatment for rheumatoid arthritis seems to work better than using either medicine alone, research indicates. About 1 percent of people have rheumatoid ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Prior studies ...

I just had an interesting experience with CVS Caremark. A few days ago, I saw a patient who had failed both Remicade® and Xeljanz® (she received the latter in a clinical trial at my practice). Given ...

Please provide your email address to receive an email when new articles are posted on . Methotrexate increases the probability of remission with adalimumab or infliximab by 50% in patients with ...

In November 2000, Immunex (Seattle, WA) initiated a patient enrollment program designed to increase year-end sales of its anti-inflammatory drug Enbrel. Immunex claims the program was implemented ...

WILMINGTON, Del., Oct 28 (Reuters) - A British charitable trust filed a patent infringement suit against Wyeth and Amgen on Wednesday over their blockbuster Enbrel drug, one of the world's ...